|
1
|
Updated clinical classification of pulmonary hypertension.
|
J Am Coll Cardiol
|
2009
|
12.05
|
|
2
|
Hepatopulmonary syndrome--a liver-induced lung vascular disorder.
|
N Engl J Med
|
2008
|
4.71
|
|
3
|
Diagnosis and differential assessment of pulmonary arterial hypertension.
|
J Am Coll Cardiol
|
2004
|
3.63
|
|
4
|
Pulmonary arteriovenous malformations.
|
Chest
|
2013
|
2.77
|
|
5
|
Clinical risk factors for portopulmonary hypertension.
|
Hepatology
|
2008
|
2.62
|
|
6
|
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
|
Chest
|
2005
|
2.60
|
|
7
|
Portopulmonary hypertension and hepatopulmonary syndrome.
|
Lancet
|
2004
|
2.48
|
|
8
|
Natural history of hepatopulmonary syndrome: Impact of liver transplantation.
|
Hepatology
|
2005
|
2.05
|
|
9
|
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.
|
Gastroenterology
|
2010
|
1.60
|
|
10
|
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.
|
Arch Intern Med
|
2008
|
1.57
|
|
11
|
Health-related quality of life and survival in liver transplant candidates.
|
Liver Transpl
|
2010
|
1.55
|
|
12
|
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates.
|
Gastroenterology
|
2008
|
1.50
|
|
13
|
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era.
|
Hepatology
|
2013
|
1.50
|
|
14
|
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.
|
Hepatology
|
2003
|
1.46
|
|
15
|
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
|
Am J Respir Crit Care Med
|
2009
|
1.44
|
|
16
|
Many faces of portopulmonary hypertension.
|
J Pediatr
|
2005
|
1.38
|
|
17
|
Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
|
Liver Transpl
|
2006
|
1.26
|
|
18
|
Pulmonary hypertension is associated with reduced patient survival after kidney transplantation.
|
Transplantation
|
2008
|
1.23
|
|
19
|
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
|
Chest
|
2005
|
1.20
|
|
20
|
The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis.
|
Chest
|
2005
|
1.11
|
|
21
|
Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.
|
Am J Respir Crit Care Med
|
2002
|
1.08
|
|
22
|
Pulmonary alveolar proteinosis.
|
Can Respir J
|
2012
|
1.03
|
|
23
|
Pulmonary hypertension in patients with interstitial lung diseases.
|
Mayo Clin Proc
|
2007
|
1.00
|
|
24
|
Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis.
|
Mayo Clin Proc
|
2004
|
0.99
|
|
25
|
Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension.
|
Chest
|
2010
|
0.95
|
|
26
|
Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment.
|
Clin Chest Med
|
2004
|
0.91
|
|
27
|
Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary vein.
|
Am J Med Sci
|
2006
|
0.90
|
|
28
|
Successful coil embolization of mediastinal bronchial artery aneurysm.
|
J Vasc Interv Radiol
|
2010
|
0.89
|
|
29
|
Portopulmonary hypertension: state of the art.
|
Ann Hepatol
|
2008
|
0.84
|
|
30
|
Portopulmonary hypertension.
|
Clin Chest Med
|
2007
|
0.84
|
|
31
|
Arterial oxygenation associated with portopulmonary hypertension.
|
Chest
|
2002
|
0.83
|
|
32
|
Serotonin transporter polymorphisms in patients with portopulmonary hypertension.
|
Chest
|
2009
|
0.83
|
|
33
|
Tracheal myxoma: a rare benign tracheal tumor.
|
Mayo Clin Proc
|
2004
|
0.82
|
|
34
|
Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease.
|
J Pediatr Surg
|
2008
|
0.82
|
|
35
|
Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
|
Liver Transpl
|
2013
|
0.82
|
|
36
|
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.
|
COPD
|
2012
|
0.82
|
|
37
|
Screen for portopulmonary hypertension, especially in liver transplant candidates.
|
Cleve Clin J Med
|
2008
|
0.81
|
|
38
|
Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension.
|
Med Sci Monit
|
2008
|
0.81
|
|
39
|
Portopulmonary hypertension and the issue of survival.
|
Liver Transpl
|
2005
|
0.80
|
|
40
|
Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.
|
Liver Transpl
|
2008
|
0.80
|
|
41
|
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.
|
Gastroenterology
|
2011
|
0.80
|
|
42
|
Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival.
|
J Thorac Oncol
|
2011
|
0.80
|
|
43
|
Plasma levels of S100A4 in portopulmonary hypertension.
|
Biomarkers
|
2009
|
0.79
|
|
44
|
Editorial: Pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from "primary" pulmonary hypertension.
|
Liver Transpl
|
2002
|
0.78
|
|
45
|
Survival benefits of liver transplant in severe hepatopulmonary syndrome.
|
Am J Respir Crit Care Med
|
2013
|
0.77
|
|
46
|
Cardiovascular collapse induced by position-dependent pulmonary vein occlusion in a patient with fibrosing mediastinitis.
|
Anesthesiology
|
2005
|
0.77
|
|
47
|
The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension.
|
Crit Care Med
|
2005
|
0.77
|
|
48
|
Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation.
|
Leuk Lymphoma
|
2004
|
0.76
|
|
49
|
The impact of left ventricular hypertrophy on survival in candidates for liver transplantation.
|
Liver Transpl
|
2014
|
0.75
|
|
50
|
Transthoracic echocardiography screening for the detection of portopulmonary hypertension: a work in progress.
|
Liver Transpl
|
2013
|
0.75
|
|
51
|
Hepatopulmonary syndrome: monitoring at your fingertip.
|
Dig Dis Sci
|
2011
|
0.75
|
|
52
|
Response.
|
Chest
|
2014
|
0.75
|
|
53
|
What's new in the treatment of portopulmonary hypertension?
|
Expert Rev Gastroenterol Hepatol
|
2015
|
0.75
|
|
54
|
Discordant alpha-1 antitrypsin phenotype and genotype results in a liver transplant patient.
|
Clin Chim Acta
|
2010
|
0.75
|
|
55
|
Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
|
Transplantation
|
2017
|
0.75
|
|
56
|
Pulmonary Vascular Complications of Liver Disease.
|
Int Anesthesiol Clin
|
2017
|
0.75
|